蓝丰生化(002513.SZ)：2025年度拟计提资产减值准备约8675.64万元

Core Viewpoint - The company, Bluefeng Biochemical (002513.SZ), plans to recognize an asset impairment provision totaling approximately 86.76 million yuan by the end of 2025, following an asset impairment test on various asset categories [1] Group 1: Asset Impairment Details - The asset categories subject to impairment testing include accounts receivable, other receivables, long-term receivables, inventory, long-term equity investments, and fixed assets [1] - The total amount of the impairment provision to be recognized for the year 2025 is approximately 86.76 million yuan [1] - The accuracy of this impairment provision has not yet been audited by the annual audit accounting firm [1]